Sopra Steria extends strategic collaboration with Red Hat to industrialise sovereign-ready embedded AI
15-06-2026 20:48 via prnewswire.com

Sopra Steria extends strategic collaboration with Red Hat to industrialise sovereign-ready embedded AI

PARIS, June 15, 2026 /PRNewswire/ -- Sopra Steria today announced an extension of its strategic collaboration with Red Hat, the world's leading provider of open source solutions, to industrialise sovereign-ready embedded AI, from the data centre to the most constrained field equipment....
Read more »

PR Public relations news



SHLY™ Deck & Fence Expands to Columbus, Ohio
SHLY™ Deck & Fence Expands to Columbus, Ohio
Simpson Manufacturing Co., Inc. Publishes Fiscal 2025 Corporate Social Responsibility Report
Simpson Manufacturing Co., Inc. Publishes Fiscal 2025 Corporate Social Responsibility Report
Gold Royalty Announces Acquisition of Additional Interest in REN Royalty, Release of 2026 Integrated Report and Reminds Shareholders of Capital Markets Day
CIVISTA BANCSHARES, INC. ANNOUNCES SECOND QUARTER 2026 EARNINGS RELEASE DATE
CIVISTA BANCSHARES, INC. ANNOUNCES SECOND QUARTER 2026 EARNINGS RELEASE DATE
Bull Moose Tube Company Set to Acquire Hanna Steel Corporation
Aviation Capital Group Announces Move to New Global Headquarters in Newport Beach
Aviation Capital Group Announces Move to New Global Headquarters in Newport Beach
Trella Health Launches Physician Group Explore & Analyze to Help Post-Acute Organizations Identify High-Value Referral Opportunities
Trella Health Launches Physician Group Explore & Analyze to Help Post-Acute Organizations Identify High-Value Referral Opportunities
HelloNation Article Examines Fine Art Printing with Insights from Art Print Expert Henry McCoy
HelloNation Article Examines Fine Art Printing with Insights from Art Print Expert Henry McCoy
The Lustgarten Foundation Honors Pioneers in Pancreatic Cancer Research at Annual Inspiring Hope Gala
The Lustgarten Foundation Honors Pioneers in Pancreatic Cancer Research at Annual Inspiring Hope Gala
Le Groupe Menarini présente les résultats de l'essai clinique SENTRY de phase III sur l'association selinexor-ruxolitinib dans le traitement de la myélofibrose lors du congrès 2026 de l'Association européenne d'hé
Le Groupe Menarini présente les résultats de l'essai clinique SENTRY de phase III sur l'association selinexor-ruxolitinib dans le traitement de la myélofibrose lors du congrès 2026 de l'Association européenne d'hé
Frost & Sullivan Institute Celebrates Visionary Companies Addressing the World's Most Pressing Challenges
Safehold Closes $225 Million Private Placement of Structured Senior Unsecured Notes Due 2056
Safehold Closes $225 Million Private Placement of Structured Senior Unsecured Notes Due 2056
RED ROBIN GOURMET BURGERS, INC. ANNOUNCES TWO ADDITIONAL REFRANCHISING AGREEMENTS
Neurocrine Biosciences Presents First Retrospective Case Series of CRENESSITY® (crinecerfont) in Patients with Classic Congenital Adrenal Hyperplasia Due to 11β‑Hydroxylase Deficiency at ENDO 2026
Neurocrine Biosciences Presents First Retrospective Case Series of CRENESSITY® (crinecerfont) in Patients with Classic Congenital Adrenal Hyperplasia Due to 11β‑Hydroxylase Deficiency at ENDO 2026
Desktop versie